Results 21 to 30 of about 20,611 (192)

Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma

open access: yesJournal of Genetic Engineering and Biotechnology, 2021
Background Livin/BIRC7 is a member of the inhibitors of apoptosis proteins family which are implicated in development of cancer through the inhibition of apoptosis process.
Basma K. Elmekkawy   +4 more
doaj   +1 more source

Correlation of color Doppler ultrasound and pathological grading in endometrial carcinoma

open access: yesJournal of Family Medicine and Primary Care, 2020
Introduction: Given the role of angiogenesis in tumor growth, the evaluation of tissue vascularization by Doppler ultrasound has been thought to be useful in the prediction of malignant endometrial changes.
Azar Ahmadzade   +2 more
doaj   +1 more source

Recurrent endometrial atypical hyperplasia diagnosed by pathological examination of the placenta from a live birth: a case report

open access: yesBMC Pregnancy and Childbirth, 2023
Background Pregnancy complicated with endometrial atypical hyperplasia, which is often observed during early pregnancy, is extremely rare. Case presentation The patient was a 30-year-old woman who had premature delivery at 30+ 1 weeks gestation, and ...
Weilu Wu, Wei Wang, Juan Zou
doaj   +1 more source

DNA methylation of selected tumor suppressor genes in endometrial hyperplasia

open access: yesBiomedical Papers
Aims. To investigate DNA methylation of specific gene promoters in endometrial hyperplasia compared to normal endometrial tissue. Materials and Methods.
Ondrej Dvorak   +4 more
doaj   +1 more source

Bcl-2 May Contribute to Evolution of Endometrial Hyperplasia, but It Isn’t a Factor in Subsequent Carcinogenesis [PDF]

open access: yesArchives of Razi Institute
Endometrial carcinoma is common in the western world and is increasing in frequency in developing countries as well. Endometrial hyperplasia is considered to be a precancerous lesion.
Athulya Krishna Kumar   +2 more
doaj   +1 more source

Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia [PDF]

open access: yesInternational Journal of Fertility and Sterility, 2016
Background The endometrial hyperplasia measured by ultrasound in polycystic ovary syndrome (PCOS) women is strongly related to pathologic endometrial thickness, but there is no consensus on the relation between serum luteinizing hormone (LH) and either ...
Fariba Ramezanali   +4 more
doaj   +1 more source

Coexisting adenomyosis in endometriosis: Similar pain and quality of life, with longer bleeding and bowel symptoms—A comparative cross‐sectional study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare pain, menstrual flow, and quality of life (QoL) between women undergoing surgery for endometriosis only compared with women with endometriosis and coexisting adenomyosis. Methods A cross‐sectional study, set in two tertiary hospitals, of reproductive‐aged women (18–50 years) with a preoperative imaging diagnosis of ...
Mariana Matzenbacher Brunoro   +5 more
wiley   +1 more source

An altered uterine microbiota with endometrial hyperplasia

open access: yesBMC Microbiology
Background Endometrial hyperplasia (EH) is a precursor to endometrial cancer, and the role of the microbiome in its development is unclear. Results The present study investigated the uterine microbiome in patients with benign uterine conditions and ...
Xue Ying   +3 more
doaj   +1 more source

Preoperative and postoperative pathology concordance in endometrial intraepithelial neoplasia: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To assess the concordance between pre‐ and postoperative pathology in patients with endometrial intraepithelial neoplasia (EIN) undergoing hysterectomy, and identify predictors of malignancy, including sampling method, progestin therapy, and surgical timing.
Jenny Dimakos   +6 more
wiley   +1 more source

Efficacy and related factors of levonorgestrel‐releasing intrauterine system combined with metformin in fertility‐preserving treatment for atypical endometrial hyperplasia and early endometrial cancer: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare the efficacy of the levonorgestrel‐releasing intrauterine system combined with metformin versus oral progestin combined with metformin in fertility‐preserving treatment for patients with atypical endometrial hyperplasia and early endometrial cancer, and to analyze related factors affecting efficacy.
Pengpeng Gu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy